title: [Systemic sclerosis - an update].
authors.affiliation: Medizinische Klinik 3, Universität Erlangen-Nürnberg.
authors.forename: Christina
authors.initials: C
authors.lastname: Bergmann
authors.affiliation: Medizinische Klinik 3, Universität Erlangen-Nürnberg.
authors.forename: Jörg H W
authors.initials: JH
authors.lastname: Distler
mesh_terms: D000465:Algorithms; D000818:Animals; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D065128:Endothelin Receptor Antagonists / Q000627:therapeutic use; D006162:Guanylate Cyclase / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D007211:Indoles / Q000627:therapeutic use; D011651:Pulmonary Artery / Q000503:physiopathology; D011720:Pyrazoles / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D000069283:Rituximab; D012595:Scleroderma, Systemic / Q000145:classification / Q000150:complications / Q000628:therapy; D013449:Sulfonamides / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D065128:Endothelin Receptor Antagonists; D007211:Indoles; D011720:Pyrazoles; D011728:Pyridones; D011743:Pyrimidines; D013449:Sulfonamides; D000069283:Rituximab; C093844:pirfenidone; D006162:Guanylate Cyclase; C530716:nintedanib; C542595:riociguat; C533860:macitentan